FBP2 Activators

FBP2, commonly known as KHSRP (KH-type splicing regulatory protein), is a multifunctional protein involved in RNA metabolism, decay, and microRNA processing. The chemical class denoted as FBP2 Activators encompasses a range of compounds that can influence the activity or expression of this protein, either directly or through the modulation of related pathways. Actinomycin D is a DNA-binding agent that inhibits RNA synthesis, thereby potentially affecting proteins like KHSRP that bind and regulate RNA. In the same vein, 5-Azacytidine acts as a DNA methyltransferase inhibitor and has the ability to modulate the expression of various genes, including factors that can be associated with KHSRP. mTOR inhibitors, with Rapamycin as a representative member, target the mTOR signaling pathway, which in turn can influence mRNA decay pathways where KHSRP operates. Tunicamycin induces endoplasmic reticulum (ER) stress, and given the interconnected nature of cellular processes, it can have a bearing on RNA binding proteins, including KHSRP. Cycloheximide, known to inhibit protein synthesis, can alter the levels and activities of RNA-binding proteins, with potential effects on KHSRP.

Furthermore, MG132 is a proteasome inhibitor and stabilizes proteins, possibly affecting KHSRP levels. Staurosporine is a kinase inhibitor, having implications for signaling pathways intertwined with RNA metabolism. Leptomycin B's inhibition of nuclear export can bear upon nuclear RNA-binding proteins like KHSRP. Chloroquine's modulation of the endosomal pathway might have repercussions on microRNA processing, where KHSRP plays a role. Ionomycin, a calcium ionophore, can alter cellular signaling and thus influence KHSRP's function. Calyculin A's inhibition of protein phosphatases can touch upon RNA processing and splicing. Finally, Brefeldin A, which disrupts ER-to-Golgi transport, can indirectly affect RNA metabolism and associated proteins.